Solara Pharma’s manufacturing site garners positive FDA review
Solara Active Pharma Sciences Ltd's (Solara Pharma) manufacturing facility in Cuddalore has garnered approval from the US Food and Drug Administration (US FDA). Following an ... Read More
Solara Active Pharma gets CEP of Ranitidine API restored by EDQM
Solara Active Pharma Sciences said that its certificates of suitability (CEP) for Ranitidine Hydrochloride drug substance (CEP 2001-228) has been restored by the European Directorate ... Read More